+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Ophthalmic Viscosurgical Devices Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 184 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968738
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior leaders in ophthalmic devices are operating amid constant advances in surgical technology, growing clinical demands, and evolving supply chain complexity. This analysis provides actionable insight so B2B executives can optimize strategy in a competitive, innovation-driven marketplace.

Market Snapshot: Ophthalmic Viscosurgical Devices Market

The ophthalmic viscosurgical devices market demonstrated significant momentum, growing from USD 702.86 million in 2024 to USD 765.93 million in 2025, and is set to achieve a strong compound annual growth rate of 9.12% through 2032, ultimately reaching USD 1.41 billion. This upward trend is propelled by expanding adoption of advanced viscoelastic solutions, supporting greater efficiency and precision in surgical procedures such as cataract, corneal, glaucoma, and vitreoretinal interventions. Both established players and innovative entrants are influencing market direction, notably through ongoing investments in research and product development. Heightened clinical expectations drive demand for differentiated products and responsive post-sale support, reinforcing the need for adaptable business models.

Scope & Segmentation of the Ophthalmic Viscosurgical Devices Market

This report breaks down the complex ophthalmic viscosurgical devices sector by critical segmentation criteria and geographic trends. This nuanced segmentation aids precise targeting, commercial planning, and risk assessment across the value chain. Key segmentation areas include:

  • Product Types: Cohesive, dispersive, combined, and viscoadaptive solutions support the spectrum of modern ophthalmic surgeries and distinct surgeon requirements.
  • Composition: Sodium hyaluronate, hydroxypropyl methylcellulose, and combinations offer tailored viscosity levels and biocompatibility for surgical performance and patient safety.
  • Applications: Devices are engineered for cataract, corneal, glaucoma, and vitreoretinal procedures, reflecting their adaptability to diverse clinical needs and evolving patient populations.
  • End Users: Ambulatory surgery centers, general hospitals, and specialized clinics each present unique operational priorities and purchasing behaviors for suppliers.
  • Distribution Channels: Direct sales, partnerships with distributors, and ecommerce platforms expand market penetration while enabling scale and flexibility in delivery.
  • Regions: Comprehensive coverage includes the Americas (North and Latin America), Europe, Middle East and Africa (with country-level granularity), and Asia-Pacific, supporting refined localization strategies and distributor alignment.
  • Leading Companies: Company profiles and competitive benchmarking focus on Alcon Laboratories, Johnson & Johnson, Bausch + Lomb, Carl Zeiss Meditec, HOYA Surgical Optics, Santen Pharmaceutical, Rayner Group, Nordic Pharma, Bohus BioTech, and BVI Medical, illustrating varied innovation and growth approaches in the sector.

Key Takeaways for Senior Decision-Makers

  • Technological advances in viscoelastic polymers and device delivery are enabling support for more specialized and complex surgical techniques, while also meeting surgeon preferences.
  • Collaboration between device manufacturers and laser system suppliers is enhancing integration, resulting in more efficient workflows and improved patient care dynamics.
  • New entrants and innovators are introducing viscoadaptive products, refreshing the competitive landscape and shaping perception among clinicians and procurement specialists.
  • Regional differences in procedure rates, reimbursement practices, and regulatory frameworks make market-specific approaches vital for long-term presence and success.
  • Streamlined supply chains and robust post-market support, such as tailored support programs, are becoming essential for both product reliability and organizational resilience in shifting compliance environments.
  • Structured surgeon training, including both virtual modules and onsite sessions, supports operative precision and fosters stronger relationships between suppliers and front-line professionals.

Tariff Impact and Supply Chain Considerations

Changes to tariff regulations in 2025 are reshaping sourcing, procurement, and logistics for ophthalmic viscosurgical devices. Suppliers have diversified raw material sourcing and are pursuing domestic manufacturing or transacting with vendors in tariff-exempt regions, ensuring stable cost control. Healthcare institutions—facing volatility in device pricing—deploy group purchasing and enhance contract terms, maintaining product quality and availability amidst regulatory shifts. Collaborative risk management among manufacturers, purchasing consortiums, and compliance agencies ensures continuity across global supply networks.

Ophthalmic Viscosurgical Devices Market: Methodology & Data Sources

The insights in this report are based on direct interviews with experienced surgeons, procurement leads, and clinical authorities, alongside a review of industry publications, regulatory submissions, and intellectual property records. Expert validation from polymer chemists and biomedical engineers reinforces the reliability of device composition and clinical performance analysis. Data triangulation is employed to substantiate findings and recommendations.

Why This Report Matters

  • Presents a practical framework for leveraging ophthalmic viscosurgical devices market trends while tailoring go-to-market plans for each operating region.
  • Details operational and supply adaptations required to address regulatory, tariff, and trade environment shifts, aiding organizational risk management.
  • Supports informed positioning with robust segmentation and peer benchmarking, strengthening both clinical and commercial strategy development.

Conclusion

This report equips senior leaders to navigate technological, regional, and regulatory developments in ophthalmic viscosurgical devices, helping drive resilient growth and strategic decision-making.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Rising adoption of advanced cohesive dispersive OVDs for complex cataract surgeries improving patient outcomes
5.2. Integration of drug-eluting ophthalmic viscosurgical devices for targeted postoperative therapy delivery
5.3. Growing demand for prefilled single-use viscoelastic injectors reducing contamination risk and procedural time
5.4. Expansion of micro-incision cataract surgery driving innovations in low-viscosity OVD formulations
5.5. Development of bioresorbable viscoelastics enhancing corneal endothelial protection and faster recovery
5.6. Strategic partnerships between device manufacturers and research institutes accelerating OVD technology advancements
5.7. Regulatory approvals of novel viscoelastic polymers enabling safer and more effective intraocular procedures
5.8. Increase in geriatric population fueling demand for specialized ophthalmic viscosurgical devices in emerging markets
5.9. Emergence of tear film-mimicking viscoelastic combinations for improved lubricity during ophthalmic interventions
5.10. Focus on cost-effective OVD solutions for high-volume surgical centers in resource-constrained regions
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Ophthalmic Viscosurgical Devices Market, by Product Type
8.1. Cohesive
8.2. Combined
8.3. Dispersive
8.4. Viscoadaptive
9. Ophthalmic Viscosurgical Devices Market, by Composition
9.1. Combination
9.2. Hydroxypropyl Methylcellulose
9.3. Sodium Hyaluronate
10. Ophthalmic Viscosurgical Devices Market, by Application
10.1. Cataract Surgery
10.2. Corneal Surgery
10.3. Glaucoma Surgery
10.4. Vitreoretinal Surgery
11. Ophthalmic Viscosurgical Devices Market, by End User
11.1. Ambulatory Surgery Centers
11.2. Hospitals
11.3. Specialty Clinics
12. Ophthalmic Viscosurgical Devices Market, by Distribution Channel
12.1. Direct Sales
12.2. Distributor Partners
12.3. Ecommerce
13. Ophthalmic Viscosurgical Devices Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Ophthalmic Viscosurgical Devices Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Ophthalmic Viscosurgical Devices Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Alcon Laboratories, Inc.
16.3.2. Johnson & Johnson
16.3.3. Bausch + Lomb Incorporated
16.3.4. Carl Zeiss Meditec AG
16.3.5. HOYA Surgical Optics, Inc.
16.3.6. Santen Pharmaceutical Co., Ltd.
16.3.7. Rayner Group
16.3.8. Nordic Pharma, Inc.
16.3.9. Bohus BioTech AB
16.3.10. BVI Medical, Inc. a
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Ophthalmic Viscosurgical Devices market report include:
  • Alcon Laboratories, Inc.
  • Johnson & Johnson
  • Bausch + Lomb Incorporated
  • Carl Zeiss Meditec AG
  • HOYA Surgical Optics, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Rayner Group
  • Nordic Pharma, Inc.
  • Bohus BioTech AB
  • BVI Medical, Inc. a

Table Information